vitoss
-
Orthovita Gets FDA Clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute
Orthovita, Inc., an orthobiologics and biosurgery company, said that it received 510(k) clearance from the U.S. Food and Drug Administration…
Read More » -
Orthovita Receives FDA Clearance for Vitoss™ Bioactive Foam-2X Bone Graft Substitute
MALVERN, Pa.–(BUSINESS WIRE)–Orthovita, Inc. (NASDAQ: VITA), an orthobiologics and biosurgery company, announced today that it received 510(k) clearance from the…
Read More »